礼来第二季度营收155.6亿美元，口服减重药临床数据未达预期

环球网08-08

【环球网财经综合报道】当地时间8月7日，美国制药企业礼来公司发布了2025年第二季度财报。财报显示，第二季度，礼来实现营收达155.6亿美元，超出华尔街预期的146.9亿美元；净利润为56.6亿美元，合每股6.29美元，而去年同期为29.7亿美元，合每股3.28美元。此外，剔除一次性无形资产相关项目后，公司调整后每股收益为6.31美元，超出市场预期的5.57美元。东方IC进一步来讲，礼来旗下两款...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2557516841?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-08-08 10:12","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2557516841","market":"us","top_or_hot":-1,"title":"礼来第二季度营收155.6亿美元，口服减重药临床数据未达预期","media":"环球网","content":"<div>\n<p>【环球网财经综合报道】当地时间8月7日，美国制药企业礼来公司发布了2025年第二季度财报。财报显示，第二季度，礼来实现营收达155.6亿美元，超出华尔街预期的146.9亿美元；净利润为56.6亿美元，合每股6.29美元，而去年同期为29.7亿美元，合每股3.28美元。此外，剔除一次性无形资产相关项目后，公司调整后每股收益为6.31美元，超出市场预期的5.57美元。东方IC进一步来讲，礼来旗下两款...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808101429a6d9e82d&s=b\">Source Link</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>礼来第二季度营收155.6亿美元，口服减重药临床数据未达预期</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n礼来第二季度营收155.6亿美元，口服减重药临床数据未达预期\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-08-08 10:12 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808101429a6d9e82d&s=b><strong>环球网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>【环球网财经综合报道】当地时间8月7日，美国制药企业礼来公司发布了2025年第二季度财报。财报显示，第二季度，礼来实现营收达155.6亿美元，超出华尔街预期的146.9亿美元；净利润为56.6亿美元，合每股6.29美元，而去年同期为29.7亿美元，合每股3.28美元。此外，剔除一次性无形资产相关项目后，公司调整后每股收益为6.31美元，超出市场预期的5.57美元。东方IC进一步来讲，礼来旗下两款...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808101429a6d9e82d&s=b\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LLY","symbol_name":"礼来","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808101429a6d9e82d&s=b","article_id":"2557516841","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808101429a6d9e82d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2557516841","pubTimestamp":1754619128,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"财报显示，第二季度，礼来实现营收达155.6亿美元，超出华尔街预期的146.9亿美元；净利润为56.6亿美元，合每股6.29美元，而去年同期为29.7亿美元，合每股3.28美元。而分析师此前预计，礼来2025年的营收约为600亿美元，每股盈利为21.74美元。虽然礼来业绩报告向好，不过当地时间8月7日，其股价收跌14.14%。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"LLY":"礼来"},"translate_title":"Eli Lilly's second-quarter revenue was US $15.56 billion, and clinical data of oral weight loss drugs missed expectations","themeId":"354707914f8b173c27b2fcf83d65ef5b","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LLY":1},"content_text":"【环球网财经综合报道】当地时间8月7日，美国制药企业礼来公司发布了2025年第二季度财报。财报显示，第二季度，礼来实现营收达155.6亿美元，超出华尔街预期的146.9亿美元；净利润为56.6亿美元，合每股6.29美元，而去年同期为29.7亿美元，合每股3.28美元。此外，剔除一次性无形资产相关项目后，公司调整后每股收益为6.31美元，超出市场预期的5.57美元。东方IC进一步来讲，礼来旗下两款药物成为业绩增长的驱动力。其中，糖尿病治疗药物Mounjaro当季营收近52亿美元，同比增长68%；减重药Zepbound单季销售额达33.8亿美元，同比激增172%。基于此，礼来上调了全年业绩预期，预计2025年全年调整后每股收益为21.75至23美元，较此前预估的20.78至22.28美元有所上调；预计今年的年销售额将在600亿至620亿美元之间，高于此前580亿至610亿美元的区间。而分析师此前预计，礼来2025年的营收约为600亿美元，每股盈利为21.74美元。虽然礼来业绩报告向好，不过当地时间8月7日，其股价收跌14.14%。消息面上，礼来公布的最新临床数据显示，在超过3000名肥胖或至少伴有一种体重相关合并症的超重但无糖尿病的成人中，每日服用一次的GLP-1口服减重药Orforglipron，在72周用药时，最高剂量组平均减重12.4kg，减重幅度达12.4%，这一结果未达市场预期。（南木）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2557516841","isCrawlerRequest":true}